Many people in poor countries die from diseases that are curable because they cannot afford the medication required. Do you believe that drug companies should make their products available at reduced prices in these countries?

Over the past few decades, there has been a tremendous increase in the mortality rates

due to

curable diseases among individuals residing in less wealthy

countries

.

This

is primarily because of the lack of funds required for appropriate medical attention.

This

essay will discuss the reasons for high death rates and highlight possible interventions from pharmaceutical companies to help

this

cause.

To begin

, the main reason for individuals dying from illnesses that have an established treatment in poor

countries

is the lack of monetary means to access good quality healthcare facilities.

This

is because the economy in

such

countries

is unstable.

As a result

, a large proportion of the population is unemployed.

Therefore

, they cannot afford the costs of treating the disease.

For instance

, a recent study in Africa revealed that around 60% of the deaths reported in 2019 were a consequence of poor financial conditions. To combat the loss of valuable human life, pharmaceutical companies could provide subsidies in less wealthy

countries

.

This

would ensure that every person has the capacity to purchase the required medication to alleviate the symptoms and potentially get cured of a specific disease.

This

would result in a significant decrease in the number of people dying from diseases which could

otherwise

be cured. In conclusion, the loss of human lives in poor

countries

directly correlates to the lack of funds and pharmaceutical institutions play a crucial role in lowering these figures. In my opinion,

such

companies certainly have to consider the hardships faced by these people and provide their services at a reduced cost.